share_log

B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13

B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13

B of A Securities以中性评级启动对Inovio制药的覆盖,宣布目标价为13美元
Benzinga Real-time News ·  2021/03/23 19:25

B of A Securities initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral rating and announces Price Target of $13.

美国银行证券启动对Inovio制药的覆盖(纳斯达克:伊诺)评级为中性,并宣布目标价为13美元。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发